Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors

Clinical trial NCT00794131 · COMPLETED

Trial details

NCT number: NCT00794131
Sponsor: Genelux GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers (Solid Tumors)

Start date: 2008-11-01
Primary completion: 2015-11-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.